Pyrrolothiazine and pyrrolothiazephine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
AssigneeDaiichi Suntory Pharma Co., Ltd.
InventorsAkira MIZUNO, Makoto SHIBATA, Tomoe KAMEI, Harukazu FUKAMI, Norio INOMATA
Life of this patent
Estimating the term…
Abstract
Abstract of the Disclosure A pyrrolesulfonamide derivative, Compound (I), which has strong serotonin-2 receptor antagonistic action and low toxicity and less side effects, and is useful as a therapeutic for circulatory diseases such as ischemic heart diseases, cerebrovascular disturbances and peripheral circulatory disturbances.
Claims27
A pyrrolesulfonamide derivative or a salt thereof, said pyrrolesulfonamide derivative being represented by the following formula (I):
- wherein
- the ring p represented by
- means a pyrrole ring represented by the following structure:
- in which R represents an alkyl group, a cycloalkyl group, a cycloalkyl-alkyl group or a substituted or unsubstituted aralkyl group;
- the dashed line indicates the presence or absence of a bond;
- and, when the bond indicated by the dashed line is present, Z2 is not present and Z1 represents a hydrogen atom but, when the bond indicated by the dashed line is absent, Z1 represents a hydrogen atom and Z2 represents a hydroxyl group;
- or Z1 and Z2 are combined together to represent an oxygen atom or a group NOR1 in which R1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aralkyl group or a substituted or unsubstituted aryl group;
- l represents 0 or 1;
- A represents a substituted or unsubstituted alkylene group, a substituted or unsubstituted alkenylene group or a substituted or unsubstituted alkynylene group;
- and
- Y represents a group
- in which W represents CH, C═ or a nitrogen atom;
- and, when W represents CH, m stands for 0 or 1, B represents a carbonyl group, a sulfonyl group, an alkylene group, an alkenylene group, a group -C(OH)R2- in which R2 represents a substituted or unsubstituted aryl group, a group -CHR3- in which R3 represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted cyclic or acyclic acetal group;
- when W represents C═, m stands for 1, B represents a group
- in which the double bond is coupled with W and R4 represents a substituted or unsubstituted aryl group-or a substituted or unsubstituted aralkyl group;
- when W represents a nitrogen atom, m stands for 0 or 1, and B represents a carbonyl group, a sulfonyl group, an alkylene group, an alkenylene group or a group -CHR5- in which R5 represents a substituted or unsubstituted aryl group;
- E1 and E2 each independently represents a hydrogen atom or a lower alkyl group;
- and D represents a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted aromatic heterocyclic group.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ia):
- wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
- reacting a compound, which is represented by the following formula (III):
- X-A-X’ (III)
- wherein A has the same-meaning as defined above and X and X’ represent the same or different eliminative groups, to a compound represented by the following formula (II):
- wherein the ring P and l have the same meanings as defined above, thereby obtaining a compound represented by the following formula (IV):
- wherein A, the ring P, X and l have the same meanings as defined above;
- and then
- reacting a nitrogen-containing compound represented by the following formula (V):
- H-Y (V)
- wherein Y has the same meaning as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ia):
- wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
- reacting a compound, which is represented by the following formula (VI):
- X-A-Y (VI)
- wherein A, X and Y have the same meanings as defined above, to a compound represented by the following formula (II):
- wherein the ring P and l have the same meanings as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ic):
- wherein A, the ring P, R1 and l have the same meanings as defined above, and Y’ represents a group
- in which when W represents CH, B’ represents a sulfonyl group, an alkylene group, an alkenylene group, a group -C(OH)R2- in which R2 represents a substituted or unsubstituted aryl group, a group -CHR3- in which R3 represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted cyclic or acyclic acetal group;
- when W represents C═, B’ represents a group
- in which the double bond is coupled with W and R4 represents a substituted or unsubstituted aryl group or a substituted or unsubstituted aralkyl group;
- when W represents a nitrogen atom, B’ represents a carbonyl group, a sulfonyl group, an alkylene group, an alkenylene group or a group -CHR5- in which R5 represents a substituted or unsubstituted aryl group;
- and D, E1, E2 and m have the same meanings as defined above, which comprises:
- reacting a hydroxylamine or a derivative thereof, which is represented by the following formula (VII):
- NH2OR1 (VII)
- wherein R1 has the same meaning as defined above, with a pyrrolesulfonamide derivative represented by the following formula (Ib):
- wherein A, the ring P, Y’ and l have the same meanings as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Id):
- wherein A, the ring P, Y’ and l have the same meanings as defined above, which comprises:
- reducing a pyrrolesulfonamide derivative represented by the following formula (Ib):
- wherein A, the ring P, Y’ and l have the same meanings as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ie):
- wherein A, the ring P, R1, Y and l have the same meanings as defined above, which comprises:
- reacting a hydroxylamine or a derivative thereof, which is represented by the following formula (VII):
- NH2OR1 (VII)
- wherein R1 has the same meaning as defined above, to a compound represented by the following formula (IV):
- wherein A, the ring P, X and l have the same meanings as defined above, thereby obtaining a compound represented by the following formula (VIII):
- wherein A, the ring P, R1, X and l have the same meanings as defined above;
- and then
- reacting a nitrogen-containing compound represented by the following formula (V):
- H-Y (V)
- wherein Y has the same meaning as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (If):
- wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
- reducing a compound represented by the following formula (IV):
- wherein A, the ring P, X and l have the same meanings as defined above, thereby obtaining a compound represented by the following formula (IX):
- wherein A, the ring P, X and l have the same meanings as defined above;
- and then reacting a nitrogen-containing compound represented by the following formula (V):
- H-Y (V)
- wherein Y has the same meaning as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ig):
- wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
- subjecting a compound, which is represented by the following formula (IX):
- wherein A, the ring P, X and l have the same meanings as defined above, to dehydration treatment, thereby obtaining a compound represented by the following formula (X):
- wherein A, the ring P, X and l have the same meanings as defined above;
- and then
- reacting a nitrogen-containing compound represented by the following formula (V):
- H-Y (V)
- wherein Y has the same meaning as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (Ig):
- wherein A, the ring P, Y and l have the same meanings as defined above, which comprises:
- subjecting a compound, which is represented by the following formula (If):
- wherein A, the ring P, Y and l have the same meanings as defined above, to dehydration treatment.
A compound represented by the following formula (II):
- wherein the ring P and l have the same meanings as defined above.
A compound represented by the following formula (XI):
- wherein the dashed line, A, the ring P, X, Z1, Z2 and l have the same meanings as defined above.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (IIa) or (IIa’):
- wherein R and l have the same meanings as defined above, which comprises:
- converting a 1-substituted-pyrrole-3-sulfonic acid or a salt thereof, which is represented by the following formula (XII):
- wherein M represents a hydrogen ion, an alkali metal ion, an alkaline earth metal ion or a quaternary ammonium ion, p stands for 1 when M represents a hydrogen ion, an alkali metal ion or a quaternary ammonium ion or p stands for 2 when M represents an alkaline earth metal ion, q stands for 0 or 1, and R has the same meaning as defined above, into a compound represented by the following formula (XIII):
- wherein X” represents a chlorine atom or a bromine atom;
- causing glycine or β-alanine or a derivative thereof, which is represented by the following formula (XIV):
- NH2(CH2)lCH2COOR6 (XIV)
- wherein R6 represents a hydrogen atom or a carboxyl-protecting group, to act, thereby obtaining a compound represented by the following formula (XV):
- wherein R, R6 and l have the same meanings as defined above;
- and then subjecting said compound to ring closure.
A process for the preparation of a pyrrolesulfonamide derivative represented by the following formula (IIa) or (IIa’):
- wherein R and l have the same meanings as defined above, which comprises:
- reacting a compound, which is represented by the formula (XVIa) or (XVIb):
- R-X”’ (XVIa) (RO)2SO2 (XVIb)
- wherein X”’ represents an eliminative group and R has the same meaning as defined above, with a compound represented by the following formula (IIb) or (IIb’):
- wherein l has the same meaning as defined above.
A compound represented by the following formula (XV):
- wherein R, R6 and l have the same meanings as defined above.
A compound represented by the following formula (XII):
- wherein M, R, p and q have the same meanings as defined above.
A process for the preparation of a 1-substituted-pyrrole-3-sulfonic acid or a salt thereof, which comprises treating a 1-substituted-pyrrole with sulfur trioxide-pyridine complex.
A process for the preparation of a compound represented by the following formula (XII):
- wherein M, R, p and q have the same meanings as defined above, which comprises treating a compound, which is represented by the following formula (XVII):
- wherein R has the same meaning as defined above, with trimethylsilyl chlorosulfonate, followed by alkali hydrolysis.
Dependencies are inferred from the claim text.